Medigene AG
MDG1
Kedudukan dalam Saham
#35250
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Harga Saham
$0.14942078
Disegerakkan terakhir: 2025-05-15
Modal Pasaran
$3.86M
Perubahan (1 hari)
0.10%
Perubahan (1 tahun)
47.84%
Negara
DE
Perdagangan Medigene AG (MDG1)
Kategori
Healthcare
Sejarah harga saham bagi Medigene AG (MDG1)
Harga penutupan tertinggi: $0.34 pada 2025-04-01
Harga penutupan terendah: $61.30 pada 2007-12-01
Harga penutupan terendah: $61.30 pada 2007-12-01
Sejarah harga saham Medigene AG dari 2007 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2025 | -69.63% |
| 2024 | -62.74% |
| 2023 | -33.26% |
| 2022 | -26.38% |
| 2021 | -24.98% |
| 2020 | -21.07% |
| 2019 | -42.42% |
| 2018 | -38.07% |
| 2017 | 37.11% |
| 2016 | 29.60% |
| 2015 | 57.57% |
| 2014 | 2.53% |
| 2013 | -8.47% |
| 2012 | -42.08% |
| 2010 | -54.73% |
| 2009 | -11.17% |
| 2008 | -21.76% |
| 2007 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $535.37 | 25.54% |
US
|
|
| $185.00 | 589.01% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $885.21 | 8.73% |
NL
|
